LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Search

Cencora Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

370.83 1.17

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

369.63

Max

373.91

Pagrindiniai rodikliai

By Trading Economics

Pajamos

906M

566M

Pardavimai

2.2B

86B

P/E

Sektoriaus vid.

43.836

108.767

Pelnas, tenkantis vienai akcijai

2.87

Dividendų pajamingumas

0.62

Pelno marža

0.659

Darbuotojai

47,000

EBITDA

858M

1B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+14.14% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.62%

2.21%

Kitas uždarbis

2026-05-06

Kitas dividendų mokėjimo data

2026-03-02

Kita Ex Dividend data

2026-05-15

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

482M

71B

Ankstesnė atidarymo kaina

369.66

Ankstesnė uždarymo kaina

370.83

Naujienos nuotaikos

By Acuity

34%

66%

80 / 352 reitingas Healthcare

Cencora Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-27 23:53; UTC

Karštos akcijos

Stocks to Watch: Aardvark Therapeutics, Blue Moon Metals

2026-02-27 22:23; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals To Acquire Apex Germanium Mine From Teck Subsidiary

2026-02-27 17:55; UTC

Karštos akcijos

Toronto Stocks Decline, But Remain On Track for Weekly Gains

2026-02-27 23:46; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Walks Away a Winner After Losing Warner Bros. to Paramount -- Barrons.com

2026-02-27 23:33; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Issuing $47 Billion of Equity at Nearly 20% Premium to Current Stock Price -- Barrons.com

2026-02-27 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2026-02-27 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-27 21:30; UTC

Uždarbis

Solventum Beat Wall Street Earnings Estimates. The Stock Falls. -- Barrons.com

2026-02-27 21:30; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Warner Terminates Netflix Deal, Ending Monthslong Saga -- Market Talk

2026-02-27 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals to Buy Apex Germanium and Gallium Mine From Teck >BMM

2026-02-27 21:17; UTC

Uždarbis

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026-02-27 21:10; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals Evaluating Options for a New Processing Line at Springer Complex to Process the Apex Material

2026-02-27 21:09; UTC

Įsigijimai, susijungimai, perėmimai

Blue Moon Metals to Acquire the Apex Germanium and Gallium Mine From Teck

2026-02-27 21:00; UTC

Uždarbis

Nike: 3Q Results to Be Released March 31 to Accommodate for Several Holidays >NKE

2026-02-27 20:31; UTC

Įsigijimai, susijungimai, perėmimai

Netflix Receives $2.8B Termination Fee Under Terminated Warner Bros. Discovery Deal

2026-02-27 20:24; UTC

Rinkos pokalbiai

Oil Gains on Increased Risk of U.S.-Iran Conflict -- Market Talk

2026-02-27 20:23; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Post Modest Gains -- Market Talk

2026-02-27 20:12; UTC

Rinkos pokalbiai

Nike Seen With Further Challenges in China -- Market Talk

2026-02-27 19:44; UTC

Rinkos pokalbiai

Gold Caps Historic Month -- Market Talk

2026-02-27 19:39; UTC

Uždarbis

These Stocks Are Today's Movers: Netflix, Paramount, Block, Sunrun, Dell, Rocket Lab, Nvidia, CoreWeave, and More -- Barrons.com

2026-02-27 19:38; UTC

Uždarbis

Earnings Could Push the Stock Market Higher. Too Bad About Everything Else. -- Barrons.com

2026-02-27 18:53; UTC

Įsigijimai, susijungimai, perėmimai

Largest U.S. Pension Takes Stake in a Hot Semi Stock, Buys More Nvidia and IonQ -- Barrons.com

2026-02-27 18:45; UTC

Uždarbis

Quantum Computing Is No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

2026-02-27 18:45; UTC

Rinkos pokalbiai

Bitcoin Stays Vulnerable in Choppy Geopolitical Situation -- Market Talk

2026-02-27 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-27 17:07; UTC

Uždarbis

Pemex Cuts 4Q Loss As Operating Results Improve

2026-02-27 17:00; UTC

Rinkos pokalbiai

Corn Rides Oil Momentum Higher -- Market Talk

2026-02-27 16:31; UTC

Rinkos pokalbiai

Canadian Economy Shows Resilience -- Market Talk

2026-02-27 16:17; UTC

Rinkos pokalbiai

Canada Economy is Struggling But More Rate Cuts Still a Long Shot -- Market Talk

2026-02-27 15:49; UTC

Uždarbis

Quantum Computing No Longer a Speculative Bet. IonQ's Surging Stock Drives Home That Point. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Cencora Inc Prognozė

Kainos tikslas

By TipRanks

14.14% į viršų

12 mėnesių prognozė

Vidutinis 418.5 USD  14.14%

Aukščiausias 440 USD

Žemiausias 400 USD

Remiantis 9 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Cencora Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

9 ratings

8

Pirkti

1

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

80 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat